Centre de rééducation de l'Hôpital du Jura

Publications

[Physical Activity and Cancer]
Beuchat-Mamie S, Sperisen N, Molnar P, Koçer S.Praxis (Bern 1994). 2018 Aug;107(17-18):965-970. doi: 10.1024/1661-8157/a003064.
 
An international survey of patients living with spasticity.
Barnes M, Kocer S, Murie Fernandez M, Balcaitiene J, Fheodoroff K.Disabil Rehabil. 2017 Jul;39(14):1428-1434. doi: 10.1080/09638288.2016.1198432. Epub 2016 Jul 6.
 
Best clinical practice in botulinum toxin treatment for children with cerebral palsy.
Strobl W, Theologis T, Brunner R, Kocer S, Viehweger E, Pascual-Pascual I, Placzek R.Toxins (Basel). 2015 May 11;7(5):1629-48. doi: 10.3390/toxins7051629.
 
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
Dressler D, Bhidayasiri R, Bohlega S, Chahidi A, Chung TM, Ebke M, Jacinto LJ, Kaji R, Koçer S, Kanovsky P, Micheli F, Orlova O, Paus S, Pirtosek Z, Relja M, Rosales RL, Sagástegui-Rodríguez JA, Schoenle PW, Shahidi GA, Timerbaeva S, Walter U, Saberi FA.J Neurol. 2017 Jan;264(1):112-120. doi: 10.1007/s00415-016-8304-z. Epub 2016 Oct 27.
 
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.Muscle Nerve. 2018 Feb;57(2):245-254. doi: 10.1002/mus.25721. Epub 2017 Aug 13.
 
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy.
Dressler D, Bhidayasiri R, Bohlega S, Chana P, Chien HF, Chung TM, Colosimo C, Ebke M, Fedoroff K, Frank B, Kaji R, Kanovsky P, Koçer S, Micheli F, Orlova O, Paus S, Pirtosek Z, Relja M, Rosales RL, Sagástegui-Rodríguez JA, Schoenle PW, Shahidi GA, Timerbaeva S, Walter U, Saberi FA.J Neurol. 2018 Apr;265(4):856-862. doi: 10.1007/s00415-018-8759-1. Epub 2018 Feb 8.
 
Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Lower Limb Spasticity Study Group.Neurology. 2017 Nov 28;89(22):2245-2253. doi: 10.1212/WNL.0000000000004687. Epub 2017 Nov 1.
 
La réhabilitation: indispensable pour les survivants d’un COVID-19 sévère
[Rehabilitation is crucial for severe COVID-19 survivors].
Grácio S, Koçer S.Rev Med Suisse. 2020 Jun 3;16(696):1170-1173.
 
Guillain-Barré syndrome in the COVID-19 era: another occasional cluster?
Tatu L, Nono S, Grácio S, Koçer S.J Neurol. 2020 Jun 23:1-3. doi: 10.1007/s00415-020-10005-3. Online ahead of print.
 
Ce site utilise des cookies à des fins de statistiques, d’optimisation et de marketing ciblé. En poursuivant votre visite sur cette page, vous acceptez l’utilisation des cookies aux fins énoncées ci-dessus. En savoir plus.